These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 21142405)

  • 1. Mycophenolate mophetil therapy for chronic immune thrombocytopenic purpura resistant to steroids, immunosuppressants, and/or splenectomy in adults.
    Colović M; Suvajdzic N; Colović N; Tomin D; Vidović A; Palibrk V
    Platelets; 2011; 22(2):153-6. PubMed ID: 21142405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycophenolate mofetil (MMF) for the treatment of steroid-resistant idiopathic thrombocytopenic purpura.
    Hou M; Peng J; Shi Y; Zhang C; Qin P; Zhao C; Ji X; Wang X; Zhang M
    Eur J Haematol; 2003 Jun; 70(6):353-7. PubMed ID: 12756016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective analysis of rituximab therapy and splenectomy in childhood chronic and refractory immune thrombocytopenic purpura.
    Ay Y; Karapinar TH; Oymak Y; Toret E; Demirag B; Ince D; Ozcan E; Moueminoglou N; Koker SA; Vergin C
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):431-5. PubMed ID: 26656905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycophenolate mofetil therapy for severe immune thrombocytopenia.
    Taylor A; Neave L; Solanki S; Westwood JP; Terrinonive I; McGuckin S; Kothari J; Cooper N; Stasi R; Scully M
    Br J Haematol; 2015 Nov; 171(4):625-30. PubMed ID: 26250874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of various treatments in the management of idiopathic thrombocytopenic purpura in the adult].
    Llamas P; Busto MJ; Díez JL; Cabrera R; Regidor C; Forés R; Sanjuán I; Briz M; Fernández MN
    Sangre (Barc); 1995 Jun; 40(3):181-5. PubMed ID: 7570269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of idiopathic thrombocytopenic purpura (ITP) in patients with refractoriness to or with contraindication for corticosteroids and/or splenectomy with immunosuppressive therapy and danazol.
    Schiavotto C; Castaman G; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):29-34. PubMed ID: 8039755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate mofetil as a treatment for refractory idiopathic thrombocytopenic purpura.
    Zhang WG; Ji L; Cao XM; Chen YX; He AL; Liu J; Zhao WH; Zou SP
    Acta Pharmacol Sin; 2005 May; 26(5):598-602. PubMed ID: 15842780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
    Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
    Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura.
    Stasi R; Stipa E; Masi M; Cecconi M; Scimò MT; Oliva F; Sciarra A; Perrotti AP; Adomo G; Amadori S
    Am J Med; 1995 May; 98(5):436-42. PubMed ID: 7733121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination immunosuppressant therapy for patients with chronic refractory immune thrombocytopenic purpura.
    Arnold DM; Nazi I; Santos A; Chan H; Heddle NM; Warkentin TE; Kelton JG
    Blood; 2010 Jan; 115(1):29-31. PubMed ID: 19897578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of 321 patients with idiopathic thrombocytopenic purpura. Retrospective analysis of the clinical features and response to therapy.
    Pamuk GE; Pamuk ON; Başlar Z; Ongören S; Soysal T; Ferhanoğlu B; Aydin Y; Ulkü B; Aktuğlu G; Akman N
    Ann Hematol; 2002 Aug; 81(8):436-40. PubMed ID: 12224000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of mycophenolate mofetil as single-agent therapy for refractory immune thrombocytopenic purpura.
    Provan D; Moss AJ; Newland AC; Bussel JB
    Am J Hematol; 2006 Jan; 81(1):19-25. PubMed ID: 16369979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of dapsone as a second-line treatment in non-splenectomized adults with immune thrombocytopenic purpura.
    Vancine-Califani SM; De Paula EV; Ozelo MC; Orsi FL; Fabri DR; Annichino-Bizzacchi JM
    Platelets; 2008 Nov; 19(7):489-95. PubMed ID: 18979360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is splenectomy necessary for immune thrombocytopenic purpura? The role of rituximab in patients with corticosteroid resistance in a single-center experience.
    Zhang C; Liu HF; Chen XH; Gao L; Gao L; Liu Y; Kong PY; Sun AH; Zhang X
    Clin Ther; 2014 Mar; 36(3):385-8. PubMed ID: 24594069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.
    Schweizer C; Reu FJ; Ho AD; Hensel M
    Ann Hematol; 2007 Oct; 86(10):711-7. PubMed ID: 17622529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel immunomodulatory treatment involving mycophenolate mofetil and corticosteroids for pediatric autoimmune cytopenias.
    Panigrahi A; Clark A; Myers J; Raj A
    Pediatr Blood Cancer; 2017 Feb; 64(2):287-293. PubMed ID: 27615037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab in the management of chronic immune thrombocytopenic purpura: an effective and safe therapeutic alternative in refractory patients.
    Peñalver FJ; Jiménez-Yuste V; Almagro M; Alvarez-Larrán A; Rodríguez L; Casado M; Gallur L; Giraldo P; Hernández R; Menor D; Rodríguez MJ; Caballero D; González R; Mayans J; Millán I; Cabrera JR;
    Ann Hematol; 2006 Jun; 85(6):400-6. PubMed ID: 16550390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Late results of splenectomy in patients with chronic immune thrombocytopenic purpura].
    Elezović I; Bosković D; Colović M; Tomin D; Suvajdzić N; Gotić M; Colović R; Popović M
    Acta Chir Iugosl; 2002; 49(3):29-34. PubMed ID: 12587445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twenty years experience with treatment of idiopathic thrombocytopenic purpura in a single department: results in 490 cases.
    Schiavotto C; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):22-8. PubMed ID: 8039754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases.
    Vianelli N; Galli M; de Vivo A; Intermesoli T; Giannini B; Mazzucconi MG; Barbui T; Tura S; Baccaranion M;
    Haematologica; 2005 Jan; 90(1):72-7. PubMed ID: 15642672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.